Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-22-022792
Filing Date
2022-09-20
Accepted
2022-09-20 17:00:39
Documents
5
Period of Report
2022-11-10

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A nby20220918_pre14a.htm PRE 14A 357794
2 a01.jpg GRAPHIC 157385
3 a02.jpg GRAPHIC 153678
4 logo01.jpg GRAPHIC 9343
5 sig01.jpg GRAPHIC 8243
  Complete submission text file 0001437749-22-022792.txt   811492
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33678 | Film No.: 221254341
SIC: 2834 Pharmaceutical Preparations